4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000226
EVP, Chief Scientific Officer sold 22,612 shares at an average $49.58 ($1,121,195)
- EVP, Chief Scientific Officer acquired 22,612 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENNETT C FRANK · EVP, Chief Scientific Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,002 | $47.34 | $662,855 | 79,756 | D |
| 2023-12-14 | Sale : show line 2 in the form 10b5-1 | −14,002 | $49.21 | $689,085 | 65,754 | D |
| 2023-12-14 | Exercise or conversion : show line 3 in the form 10b5-1 | +8,610 | $47.34 | $407,597 | 74,364 | D |
| 2023-12-14 | Sale : show line 4 in the form 10b5-1 | −8,610 | $50.19 | $432,110 | 65,754 | D |
| Open-market sales · 22,612 sh · avg $49.58 · $1,121,195 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-12-14 | Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −14,002 | $47.34 | 2024-01-02 | 14,002 | 31,223 | D |
| 2023-12-14 | Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −8,610 | $47.34 | 2024-01-02 | 8,610 | 22,613 | D |
Loading xslF345X05/edgardoc.xml…